---
annotations:
- id: PW:0001047
  parent: disease pathway
  type: Pathway Ontology
  value: Leishmaniasis pathway
authors:
- ReactomeTeam
- DeSl
description: Macrophages specializing in tissue repair or associated with a Th2-type
  immune response are more permissive to infection with leishmania, since their defense
  mechanisms are not very efficient in eliminating the parasite and can contribute
  to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4993
- /instance/WP4993
revision: null
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4993.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Macrophages specializing in tissue repair or associated with a Th2-type
    immune response are more permissive to infection with leishmania, since their
    defense mechanisms are not very efficient in eliminating the parasite and can
    contribute to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
    Reactome].
  keywords:
  - (Mg2+ cofactor)
  - (SFKs)
  - (i):GTP:Adenylate
  - (inactive)
  - (s):GTP:Adenylate
  - (z):GTP:Adenylate
  - '5HT '
  - ADAM17
  - ADAM17(1-214)
  - ADAM17(215-827)
  - 'ADAM17(215-827) '
  - ADAM17(215-827):Zn2+
  - 'ADCY1 '
  - 'ADCY2 '
  - 'ADCY3 '
  - 'ADCY4 '
  - 'ADCY5 '
  - 'ADCY6 '
  - 'ADCY7 '
  - 'ADCY8 '
  - 'ADCY9 '
  - 'ADCYAP1(132-158) '
  - 'ADCYAP1(132-169) '
  - 'ADCYAP1(82-129) '
  - 'ADCYAP1R1 '
  - 'ADM(95-146) '
  - 'ADM2(19-153) '
  - 'ADORA2A '
  - ADORA2B
  - 'ADORA2B '
  - ADORA2B:Ade-Rib
  - ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTP
  - ADP
  - 'ADR '
  - 'ADRB1 '
  - 'ADRB2 '
  - 'ADRB3 '
  - 'AHCYL1 '
  - AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramer
  - ATP
  - 'ATP '
  - 'AVP(20-28) '
  - 'AVPR2 '
  - Ade-Rib
  - 'Ade-Rib '
  - Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDP
  - Adenylate cyclase
  - 'Antigen '
  - 'ArgN-GCG(98-127) '
  - 'CALCA(83-119) '
  - 'CALCB(82-118) '
  - 'CALCR '
  - 'CALCRL '
  - CALM1
  - 'CALM1 '
  - CALM1:4xCa2+
  - 'CCA '
  - CD163
  - CD163 gene
  - CD163(1051-1156)
  - 'CD247-1 '
  - 'CD3G '
  - 'CDCA '
  - 'CGA '
  - CREB1
  - 'CRH '
  - 'CRHR1 '
  - 'CRHR2 '
  - 'CYSLTR1 '
  - CYSLTR1,CYSLTR2
  - 'CYSLTR2 '
  - Ca2+
  - 'Ca2+ '
  - 'Constitutively active orphan GPCRs '
  - 'DA '
  - DAGs
  - 'DCA '
  - 'DPEP1 '
  - DPEP1,2,3 dimers
  - 'DPEP2 '
  - 'DPEP3 '
  - 'DRD1 '
  - 'DRD5 '
  - 'FCGR1A '
  - 'FCGR3A '
  - FCGRIIIA:CD3G/CD3Z
  - 'FGR '
  - 'FSHB '
  - 'FSHR '
  - FURIN
  - 'FYN '
  - G alpha
  - G alpha (s):GTP
  - G-betagamma
  - G-protein Gs
  - G-protein alpha
  - G-protein beta-gamma
  - 'GCG(146-178) '
  - 'GCG(53-81) '
  - GDP
  - 'GDP '
  - GGT1 dimer
  - 'GGT1(1-380) '
  - 'GGT1(381-569) '
  - GGT1, 5 dimers
  - 'GGT5(1-387) '
  - 'GGT5(388-586) '
  - 'GHRH '
  - 'GHRHR '
  - 'GIP(52-93) '
  - 'GIPR '
  - 'GLP-1 (7-37) '
  - 'GLP1R '
  - 'GLP2R '
  - 'GNAI1 '
  - 'GNAI2 '
  - 'GNAI3 '
  - 'GNAS1 '
  - 'GNAS2 '
  - 'GNAT3 '
  - 'GNAZ '
  - 'GNB1 '
  - 'GNB2 '
  - 'GNB3 '
  - 'GNB4 '
  - 'GNB5 '
  - 'GNG10 '
  - 'GNG11 '
  - 'GNG12 '
  - 'GNG13 '
  - 'GNG2 '
  - 'GNG3 '
  - 'GNG4 '
  - 'GNG5 '
  - 'GNG7 '
  - 'GNG8 '
  - 'GNGT1 '
  - 'GNGT2 '
  - 'GPBAR1 '
  - 'GPHA2 '
  - 'GPHB5 '
  - 'GPR39 '
  - GTP
  - 'GTP '
  - Glucocorticoid, IL6,
  - Gly
  - Gs:Heterotrimeric
  - H2O
  - 'HCK '
  - 'HRH2 '
  - 'HTR4 '
  - 'HTR6 '
  - 'HTR7 '
  - Heterotrimeric
  - 'Hist '
  - I(1,4,5)P3
  - 'I(1,4,5)P3 '
  - 'IAPP(34-70) '
  - 'IGHG1 '
  - 'IGHG2 '
  - 'IGHG3 '
  - 'IGHG4 '
  - 'IGHV(1-?) '
  - 'IGHV1-2 '
  - 'IGHV7-81(1-?) '
  - 'IGKC '
  - 'IGKV1-12 '
  - 'IGKV1-5(23-?) '
  - 'IGKV2-28 '
  - 'IGKV2D-30 '
  - 'IGKV3D-20 '
  - 'IGKV4-1(21-?) '
  - 'IGKVA18(21-?) '
  - 'IGLC1 '
  - 'IGLC2 '
  - 'IGLC3 '
  - 'IGLC6 '
  - 'IGLC7 '
  - 'IGLV(23-?) '
  - 'IGLV1-36(1-?) '
  - 'IGLV1-40(1-?) '
  - 'IGLV1-44(1-?) '
  - 'IGLV10-54(1-?) '
  - 'IGLV11-55(1-?) '
  - 'IGLV2-11(1-?) '
  - 'IGLV2-18(1-?) '
  - 'IGLV2-23(1-?) '
  - 'IGLV2-33(1-?) '
  - 'IGLV3-12(1-?) '
  - 'IGLV3-16(1-?) '
  - 'IGLV3-22(1-?) '
  - 'IGLV3-25(1-?) '
  - 'IGLV3-27(1-?) '
  - 'IGLV4-3(1-?) '
  - 'IGLV4-60(1-?) '
  - 'IGLV4-69(1-?) '
  - 'IGLV5-37(1-?) '
  - 'IGLV5-45(1-?) '
  - 'IGLV7-43(1-?) '
  - 'IGLV7-46(1-?) '
  - 'IGLV8-61(1-?) '
  - IL10
  - 'IL10 '
  - IL10 gene
  - 'IL10 gene '
  - IL6
  - 'IL6 '
  - IL6 gene
  - 'IL6 gene '
  - 'INSL3(106-131) '
  - 'INSL3(21-55) '
  - IP3 receptor
  - 'ITPR1 '
  - 'ITPR2 '
  - 'ITPR3 '
  - ITPR:I(1,4,5)P3
  - 'Ig heavy chain V-I region EU '
  - 'Ig heavy chain V-I region HG3 '
  - 'Ig heavy chain V-II region ARH-77 '
  - 'Ig heavy chain V-II region MCE '
  - 'Ig heavy chain V-II region NEWM '
  - 'Ig heavy chain V-II region OU '
  - 'Ig heavy chain V-II region WAH '
  - 'Ig heavy chain V-III region BRO '
  - 'Ig heavy chain V-III region BUT '
  - 'Ig heavy chain V-III region CAM '
  - 'Ig heavy chain V-III region DOB '
  - 'Ig heavy chain V-III region JON '
  - 'Ig heavy chain V-III region KOL '
  - 'Ig heavy chain V-III region TRO '
  - 'Ig heavy chain V-III region WEA '
  - 'Ig kappa chain V region EV15 '
  - 'Ig kappa chain V-I region AG '
  - 'Ig kappa chain V-I region AU '
  - 'Ig kappa chain V-I region BAN '
  - 'Ig kappa chain V-I region DEE '
  - 'Ig kappa chain V-I region Daudi '
  - 'Ig kappa chain V-I region Gal '
  - 'Ig kappa chain V-I region HK101 '
  - 'Ig kappa chain V-I region Wes '
  - 'Ig kappa chain V-II region Cum '
  - 'Ig kappa chain V-II region FR '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'Ig kappa chain V-III region B6 '
  - 'Ig kappa chain V-III region POM '
  - 'Ig kappa chain V-III region VG '
  - 'Ig lambda chain V region 4A '
  - 'Ig lambda chain V-I region HA '
  - 'Ig lambda chain V-I region NEW '
  - 'Ig lambda chain V-I region NEWM '
  - 'Ig lambda chain V-I region VOR '
  - 'Ig lambda chain V-II region BOH '
  - 'Ig lambda chain V-II region MGC '
  - 'Ig lambda chain V-II region NEI '
  - 'Ig lambda chain V-II region TOG '
  - 'Ig lambda chain V-III region LOI '
  - 'Ig lambda chain V-III region SH '
  - 'Ig lambda chain V-IV region Bau '
  - 'Ig lambda chain V-IV region Hil '
  - 'Ig lambda chain V-IV region Kern '
  - 'Ig lambda chain V-VI region AR '
  - IgG
  - IgG-Ag:p-FCGRs:p-6Y-SYK:PLCG
  - IgG:LPG1G2
  - IgG:Leishmania
  - IgG:Lma
  - IgG:Lma amastigote
  - IgG:Lma antigens
  - 'IgH  heavy chain V-III region VH26 precursor '
  - L-Glu
  - 'LCHA '
  - 'LHB '
  - 'LHCGR '
  - LPG1G2
  - 'LPG1G2 '
  - LTC4
  - 'LTC4 '
  - LTC4:CyslTR1,2
  - LTD4
  - LTE4
  - 'LYN '
  - Ligand:GPCR
  - Lma amastigote
  - 'Lma amastigote surface '
  - 'MC1R '
  - 'MC2R '
  - 'MC3R(1-360) '
  - 'MC4R '
  - 'MC5R '
  - MYH9
  - 'MYH9 '
  - 'Mg2+ '
  - 'NAD+ '
  - 'NAd '
  - 'NPS '
  - 'NPSR1 '
  - 'P2RY11 '
  - 'PEA '
  - 'PGD2 '
  - 'PGE2 '
  - 'PGI2 '
  - PI(3,4,5)P3
  - 'PI(3,4,5)P3 '
  - PI(4,5)P2
  - PKA catalytic
  - PKA tetramer
  - PKA tetramer:4xcAMP
  - PLC gamma1,2
  - 'PLCG1 '
  - 'PLCG2 '
  - 'PLK2 '
  - PLK2, MAPK14
  - 'POMC(138-150) '
  - 'POMC(138-176) '
  - 'POMC(217-234) '
  - 'POMC(77-87) '
  - PPi
  - 'PRKACA '
  - PRKACA,(PRKACB,PRKACG,PRKX)
  - 'PRKACB '
  - 'PRKACG '
  - 'PRKAR1A '
  - 'PRKAR1B '
  - 'PRKAR2A '
  - 'PRKAR2B '
  - 'PRKX '
  - 'PTGDR '
  - 'PTGER2 '
  - 'PTGER4 '
  - 'PTGIR '
  - 'PTH '
  - 'PTH1R '
  - 'PTH2(62-100) '
  - 'PTH2R '
  - 'PTHLH '
  - Protein Kinase A,
  - 'RAMP1 '
  - 'RAMP2 '
  - 'RAMP3 '
  - 'RLN2(162-185) '
  - 'RLN2(25-53) '
  - 'RLN3(119-142) '
  - 'RLN3(26-52) '
  - 'RXFP1 '
  - 'RXFP2 '
  - 'SCT '
  - 'SCTR '
  - 'SRC-1 '
  - SYK
  - 'SYK '
  - Src family kinases
  - 'TAAR1 '
  - 'TAAR2 '
  - 'TAAR3 '
  - 'TAAR5 '
  - 'TAAR6 '
  - 'TAAR8 '
  - 'TAAR9 '
  - 'TSHB '
  - 'TSHR '
  - 'VIP(125-152) '
  - 'VIPR1 '
  - 'VIPR2 '
  - 'YES1 '
  - Zn2+
  - 'Zn2+ '
  - activate
  - antigens:FCGR3A:CD3
  - antigens:FCGR3A:p-CD3 dimers
  - antigens:FCGR3A:p-CD3 dimers:SYK
  - antigens:FCGR3A:p-CD3 dimers:p-6Y-SYK
  - cAMP
  - 'cAMP '
  - cAMP:PKA regulatory
  - catalytic subunits
  - clustered
  - complex
  - complexes that
  - cyclase
  - dimers
  - gene
  - 'glucocorticoid '
  - homotetramer
  - iRHOM2
  - 'p-4Y-PLCG1 '
  - 'p-6Y-CD247 '
  - 'p-6Y-SYK '
  - p-PLCG
  - p-S,T-ADAM17(215-827):Zn2+
  - p-S133-CREB1
  - 'p-S133-CREB1 '
  - p-S133-CREB1:IL10
  - p-S133-CREB1:IL6
  - 'p-T180,Y182-MAPK14 '
  - 'p-Y160,Y171-CD3G '
  - 'p-Y288,Y304-FCGR2A '
  - 'p-Y753,Y759,Y1217-PLCG2 '
  - sCD163
  - 'sCD163 '
  - sCD163:MYH9
  - subunit
  - surface
  - surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCG
  - surface:p-FCGR3As:p-6Y-SYK:PLCG
  - tetramer
  license: CC0
  name: Anti-inflammatory response favouring Leishmania parasite infection
seo: CreativeWork
title: Anti-inflammatory response favouring Leishmania parasite infection
wpid: WP4993
---